The FGF family: biology, pathophysiology and therapy

Beenken, Andrew, Mohammadi, Moosa·2009·Nature Reviews Drug Discovery
DOI 10.1038/nrd2792

Cited by (1,001)

Items 601–700 of 1,001

  1. GRP78/BIP/HSPA5 as a Therapeutic Target in Models of Parkinson’s Disease: A Mini Review
    Adaze Bijou Enogieru, Sylvester Ifeanyi Omoruyi, Donavon Charles Hiss, Okobi Eko Ekpo · 2019 · Advances in Pharmacological Sciences
  2. Muscle transcriptome analysis identifies genes involved in ciliogenesis and the molecular cascade associated with intramuscular fat content in Large White heavy pigs
    Martina Zappaterra, Silvia Gioiosa, Giovanni Chillemi, Paolo Zambonelli, R. Davoli · 2020 · PLoS ONE
  3. Anlotinib can overcome acquired resistance to EGFR‐TKIs via FGFR1 signaling in non‐small cell lung cancer without harboring EGFR T790M mutation
    Zengzhi Lian, Wenwen Du, Yang Zhang, Yulong Fu, Ting Liu, Anqi Wang, Tingting Cai, Jianjie Zhu, Yuanyuan Zeng, Zeyi Liu et al. · 2020 · Thoracic Cancer
  4. FGFR3 phosphorylates EGFR to promote cisplatin-resistance in ovarian cancer.
    Jing Zhao, Wenxi Tan, Lingyi Zhang, Jian Liu, Mengyuan Shangguan, Junyu Chen, Ben-Zheng Zhao, Yuanqing Peng, Man-Hua Cui, Shuhua Zhao · 2021 · Biochemical Pharmacology
  5. Molecularly Targeted Therapy towards Genetic Alterations in Advanced Bladder Cancer
    Jonathan Varghese Thomas, Guru Sonpavde · 2022 · Cancers
  6. Elf5, hormones and cell fate
    Heather J Lee, Christopher John Ormandy · 2012 · Trends in Endocrinology and Metabolism
  7. Deciphering the mechanism behind Fibroblast Growth Factor (FGF) induced biphasic signal-response profiles
    Jitendra Kanodia, Diana H. Chai, Jannik Vollmer, Jaeyeon Kim, Andreas Raue, Greg Finn, Birgit Schoeberl · 2014 · Cell Communication and Signaling
  8. Heparan sulfate-protein binding specificity
    Matthew A. Nugent, Joseph Zaia, Jean L. Spencer · 2013 · Biochemistry (Moscow)
  9. Fibroblast growth factor 2: good or bad guy in the joint?
    Tonia L. Vincent · 2011 · Arthritis Research & Therapy
  10. Clinically relevant fusion oncogenes: detection and practical implications
    Maxim Sorokin, Elizaveta Rabushko, Julian Markovich Rozenberg, Tharaa Mohammad, Aleksander Seryakov, Marina I Sekacheva, Anton A. Buzdin · 2022 · Therapeutic Advances in Medical Oncology
  11. The Glycosaminoglycan Side Chains and Modular Core Proteins of Heparan Sulphate Proteoglycans and the Varied Ways They Provide Tissue Protection by Regulating Physiological Processes and Cellular Behaviour
    Brooke L. Farrugia, James Melrose · 2023 · International Journal of Molecular Sciences
  12. The mood stabilizer valproate activates human FGF 1 gene promoter through inhibiting HDAC and GSK ‐3 activities
    Chien‐Yu Kao, Yi‐Chao Hsu, Jen‐Wei Liu, Don‐Ching Lee, Yu‐Fen Chung, Ing‐Ming Chiu · 2013 · Journal of Neurochemistry
  13. Brown adipose tissue: endocrine determinants of function and therapeutic manipulation as a novel treatment strategy for obesity
    Narendra L. Reddy, Bee Kang Tan, Thomas M. Barber, Harpal Singh Randeva · 2014 · BMC Obesity
  14. Deficiency of metabolic regulator FGFR4 delays breast cancer progression through systemic and microenvironmental metabolic alterations
    Yongde Luo, Chaofeng Yang, Min Ye, Chengliu Jin, James L. Abbruzzese, Mong‐Hong Lee, Sai‐Ching J. Yeung, Wallace L. McKeehan · 2013 · Cancer & Metabolism
  15. HtrA1 Is a Novel Antagonist Controlling Fibroblast Growth Factor (FGF) Signaling via Cleavage of FGF8
    Goo-Young Kim, Ho‐Young Kim, Hyun-Taek Kim, Jeong Mi Moon, Cheol‐Hee Kim, Seongman Kang, Hyangshuk Rhim · 2012 · Molecular and Cellular Biology
  16. Therapeutic and pathological roles of fibroblast growth factors in pulmonary diseases
    Elie El Agha, Werner Seeger, Savério Bellusci · 2016 · Developmental Dynamics
  17. Targeting fibroblast growth factor pathways in endometrial cancer
    Boris J. N. Winterhoff, Gottfried E. Konecny · 2016 · Current Problems in Cancer
  18. The Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes
    Maitane Izaguirre, Marı́a J. Gil, Ignacío Monreal, Fabrizio Montecucco, Gema Frühbeck, Victoria Catalán · 2017 · Current Diabetes Reports
  19. TGF-β1 Promotes Hepatocellular Carcinoma Invasion and Metastasis via ERK Pathway-Mediated FGFR4 Expression
    Jiawei Huang, Mengyuan Qiu, Li Wan, Gui Wang, Tongzhou Huang, Zhixin Chen, Songmin Jiang, Xiaokun Li, Lixiao Xie, Lin Cai · 2018 · Cellular Physiology and Biochemistry
  20. Translocation of Exogenous FGF1 and FGF2 Protects the Cell against Apoptosis Independently of Receptor Activation
    Michał Kostas, Agata Lampart, Joanna Bober, Antoni Więdłocha, Justyna Tomala, Daniel Krowarsch, Jacek Otlewski, Małgorzata Zakrzewska · 2018 · Journal of Molecular Biology
  21. FGF10 Signaling in Heart Development, Homeostasis, Disease and Repair
    Fabien Hubert, Sandy M. Payan, Francesca Rochais · 2018 · Frontiers in Genetics
  22. FXR agonist GW4064 improves liver and intestinal pathology and alters bile acid metabolism in rats undergoing small intestinal resection
    Yi Lin Cao, Yongtao Xiao, Kejun Zhou, Junkai Yan, Panliang Wang, Weihui Yan, Wei Cai · 2019 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  23. MiR-424 overexpression protects alveolar epithelial cells from LPS-induced apoptosis and inflammation by targeting FGF2 via the NF-κB pathway
    Dongliang Cheng, Changlian Zhu, Yuan Liang, Xing Yan, Changsong Shi · 2019 · Life Sciences
  24. Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators Expression Identify Distinct Molecular Subtypes of Myocardial Infarction
    Xin Shi, Yaochen Cao, Xiaobin Zhang, Chang Gu, Feng Liang, Jieyuan Xue, Hanwen Ni, Zi Wang, Yi Li, Xia Wang et al. · 2021 · Frontiers in Cell and Developmental Biology
  25. Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer
    Liping Zhang, Hui Yu, Andrzej Badzio, Theresa A. Boyle, Hans‐Ulrich Schildhaus, Xian Jun David Lu, Rafał Dziadziuszko, Jacek Jassem, Marileila Varella‐Garcia, Lynn E. Heasley et al. · 2015 · Journal of Thoracic Oncology
  26. Antibody-Mediated Inhibition of the FGFR1c Isoform Induces a Catabolic Lean State in Siberian Hamsters
    Ricardo J. Samms, Jo Edward Lewis, Alex Lory, Maxine J Fowler, Scott Cooper, Amy Warner, Paul J. Emmerson, Andrew Charles Adams, Jeni Luckett, Alan Christopher Perkins et al. · 2015 · Current Biology
  27. FGFR Inhibitors in Cholangiocarcinoma—A Novel Yet Primary Approach: Where Do We Stand Now and Where to Head Next in Targeting This Axis?
    Paulina Chmiel, Katarzyna Gęca, Karol Rawicz‐Pruszyński, Wojciech Piotr Polkowski, Magdalena Skórzewska · 2022 · Cells
  28. Fibroblast growth factor 21: An emerging pleiotropic regulator of lipid metabolism and the metabolic network
    Shuo Li, Tiande Zou, Jun Chen, Jiaming Li, Jinming You · 2023 · Genes & Diseases
  29. Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review
    Norbertus Anton Ipenburg, Koos Koole, Kin Seng Liem, Pauline M.W. van Kempen, Ron Koole, P. J. van Diest, Robert J.J. van Es, Stefan M. Willems · 2015 · Targeted Oncology
  30. Emerging roles of FGF signaling in hepatocellular carcinoma.
    Nana Zheng, Wenyi Wei, Zhiwei Peter Wang · 2016 · PubMed
  31. Regulation of fibroblast growth factor 15/19 and 21 on metabolism: in the fed or fasted state
    Dandan Guan, Lidan Zhao, Daiwen Chen, Bing Yu, Jie Yu · 2016 · Journal of Translational Medicine
  32. Growth Factor Delivery Systems for Tissue Engineering and Regenerative Medicine
    Pau Atienza‐Roca, Xiaolin Cui, Gary J. Hooper, Tim B. F. Woodfield, Khoon S. Lim · 2018 · Advances in experimental medicine and biology
  33. Emerging Structure–Function Paradigm of Endocrine FGFs in Metabolic Diseases
    Yongde Luo, Sheng Ye, Xiaokun Li, Weiqin Lu · 2019 · Trends in Pharmacological Sciences
  34. A novel long noncoding RNA FAF inhibits apoptosis via upregulating FGF9 through PI3K/AKT signaling pathway in ischemia–hypoxia cardiomyocytes
    Haojie Shi, Ming‐Wei Wang, Jiateng Sun, Hao Wang, Ya‐Fei Li, Bing‐Rui Chen, Yi Fan, Sibo Wang, Zi‐Mu Wang, Qiming Wang et al. · 2019 · Journal of Cellular Physiology
  35. FGF8 induces epithelial-mesenchymal transition and promotes metastasis in oral squamous cell carcinoma
    Yilong Hao, Yanxuan Xiao, Xiaoyu Liao, Shuya Tang, Xiaoyan Xie, Rui R Liu, Qianming Chen · 2021 · International Journal of Oral Science
  36. Fibroblast growth factor receptor ( FGFR ) gene: pathogenesis and treatment implications in urothelial carcinoma of the bladder
    Khaleel I. Al‐Obaidy, Liang Cheng C · 2021 · Journal of Clinical Pathology
  37. Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma
    Michihisa Kono, Hiroki Komatsuda, Hidekiyo Yamaki, Takumi Kumai, Ryusuke Hayashi, Risa Wakisaka, Toshihiro Nagato, Takayuki Ohkuri, Akemi Kosaka, Kenzo Ohara et al. · 2022 · OncoImmunology
  38. Cholesterol promotes clustering of PI(4,5)P2 driving unconventional secretion of FGF2
    Fabio Lolicato, Roberto Saleppico, Alessandra Griffo, Annalena Meyer, Federica Scollo, Bianca Pokrandt, Hans‐Michael Müller, Helge Ewers, Hendrik Hähl, Jean‐Baptiste Fleury et al. · 2022 · The Journal of Cell Biology
  39. FGFR3 biology and skeletal disease
    Jyoti Narayana, William A. Horton · 2015 · Connective Tissue Research
  40. Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target
    Wen‐Yue Liu, Dong-Mei Xie, Gui‐Qi Zhu, Guiqian Huang, Yi-Qian Lin, Liren Wang, Keqing Shi, Bin Hu, Martin Braddock, Yongping Chen et al. · 2014 · Expert Opinion on Therapeutic Targets
  41. Discovery of TYRA-300: First Oral Selective FGFR3 Inhibitor for the Treatment of Urothelial Cancers and Achondroplasia.
    R. Hudkins, Eric L Allen, Alexandra Balcer, I. Hoffman, Samhita Iyer, Melissa Neal, K. Nelson, M. Rideout, Qing Ye, Jacqueline H. Starrett et al. · 2024 · Journal of Medicinal Chemistry
  42. FGF21, energy expenditure and weight loss – How much brown fat do you need?
    Leon G. Straub, Christian Wolfrum · 2015 · Molecular Metabolism
  43. Role of fibroblast growth factors in elicitation of cell responses
    Caroline Laestander, Wilhelm Engström · 2013 · Cell Proliferation
  44. Affinity Selection of FGF2-Binding Heparan Sulfates for Ex Vivo Expansion of Human Mesenchymal Stem Cells
    Sampath Jeewantha Wijesinghe, Ling Ling, Sadasivam Murali, Qing Yeong Hui, Simon F.R. Hinkley, Susan Carnachan, Tracey J. Bell, Kunchithapadam Swaminathan, James Hoi Po Hui, André J. van Wijnen et al. · 2016 · Journal of Cellular Physiology
  45. Regulation of Receptor Binding Specificity of FGF9 by an Autoinhibitory Homodimerization
    Yang Liu, Jinghong Ma, Andrew Beenken, Lakshmi Srinivasan, Anna V. Eliseenkova, Moosa Mohammadi · 2017 · Structure
  46. Biomimetic Aspects of Oral and Dentofacial Regeneration
    Akshaya Upadhyay, Sangeeth Pillai, Parisa Khayambashi, Hisham Sabri, Kyungjun T. Lee, Maryam Tarar, Stephanie Zhou, Ingrid Harb, Simon D. Tran · 2020 · Biomimetics
  47. Discovery of Novel 7-Azaindole Derivatives as Selective Covalent Fibroblast Growth Factor Receptor 4 Inhibitors for the Treatment of Hepatocellular Carcinoma
    Zhenpeng Zhong, Liyang Shi, Tiancheng Fu, Jiajun Huang, Zhengying Pan · 2022 · Journal of Medicinal Chemistry
  48. Fibroblast Growth Factor 7 Suppresses Fibrosis and Promotes Epithelialization during Wound Healing in Mouse Fetuses
    Kento Takaya, Noriko Aramaki‐Hattori, Shigeki Sakai, Keisuke Okabe, Toru Asou, Kazuo Kishi · 2022 · International Journal of Molecular Sciences
  49. Bile acid signaling after an oral glucose tolerance test
    Silke Matysik, Josefine Martin, Margarita Bala, Max Scherer, Andréas Schäffler, Gerd Schmitz · 2011 · Chemistry and Physics of Lipids
  50. Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross‐talk in the bone marrow of multiple myeloma patients
    Antonio Basile, Michele Moschetta, Paolo Ditonno, Roberto Ria, Ilaria Marech, Annunziata De Luisi, Simona Berardi, Maria Antonia Frassanito, Emanuele Angelucci, Daniele Derudas et al. · 2012 · The Journal of Pathology
  51. An overview of the binding models of FGFR tyrosine kinases in complex with small molecule inhibitors
    Weiyan Cheng, Mixiang Wang, Xin Tian, Xiaojian Zhang · 2016 · European Journal of Medicinal Chemistry
  52. Puberty
    Selma Feldman Witchel, Ali Kemal Topaloglu · 2019 · Elsevier eBooks
  53. Current progress, challenges and future prospects of indazoles as protein kinase inhibitors for the treatment of cancer
    N. Tandon, Vijay Luxami, Divya M. Kant, R. Tandon, Kamaldeep Paul · 2021 · RSC Advances
  54. Keratinocyte growth factor in focus: A comprehensive review from structural and functional aspects to therapeutic applications of palifermin
    Solmaz Sadeghi, Hourieh Kalhor, Mohammad Panahi, Hoda Abolhasani, Bahareh Rahimi, Reyhaneh Kalhor, Amirmehdi Mehrabi, Mahsa Vahdatinia, Hamzeh Rahimi · 2021 · International Journal of Biological Macromolecules
  55. Nuclear receptors and metabolism: from feast to famine
    Suk-Hyun Hong, Maryam Ahmadian, Ruth T. Yu, Annette R. Atkins, Michael Downes, Ronald M. Evans · 2014 · Diabetologia
  56. Influence of Heparin Mimetics on Assembly of the FGF·FGFR4 Signaling Complex
    Krishna Saxena, Ulrich Schieborr, Oliver Anderka, Elke Duchardt, Bettina Elshorst, S.L. Gande, Julia Janzon, D. Kudlinzki, Sridhar Sreeramulu, Matthias Dreyer et al. · 2010 · Journal of Biological Chemistry
  57. High-level Expression and Purification of Active Human FGF-2 in Escherichia coli by Codon and Culture Condition Optimization
    Mohammad Reza Soleyman, Mostafa Khalili, Behzad Khansarinejad, Maryam Baazm · 2016 · Iranian Red Crescent Medical Journal
  58. Bio-orthogonal Immobilization of Fibroblast Growth Factor 2 for Spatial Controlled Cell Proliferation
    Tessa C. Lühmann, Gabriel Jones, Marcus Gutmann, J.-C. Rybak, Joachim Nickel, Marina Rubini, Lorenz Meinel · 2015 · ACS Biomaterials Science & Engineering
  59. Targeting FGFR1 to suppress leukemogenesis in syndromic and de novo AML in murine models
    Qing Wu, Aaron Bhole, Haiyan Qin, Judith E. Karp, Sami N. Malek, John Kenneth Cowell, Mingqiang Ren · 2016 · Oncotarget
  60. Chartarolides A-C, novel meroterpenoids with antitumor activities
    Dong N. Liu, Yong Li, Xiaodan Li, Zhongbin Cheng, Jian Huang, Peter Proksch, Wenhan Lin · 2017 · Tetrahedron Letters
  61. ODM-203, a Selective Inhibitor of FGFR and VEGFR, Shows Strong Antitumor Activity, and Induces Antitumor Immunity
    Tim H. Holmström, Anu‐Maarit Moilanen, Tarja Ikonen, Mari L. Björkman, Tero Linnanen, Gerd Wohlfahrt, Stefan Karlsson, Riikka Oksala, Timo Korjamo, Susanta Samajdar et al. · 2018 · Molecular Cancer Therapeutics
  62. Nuclear Fibroblast Growth Factor Receptor Signaling in Skeletal Development and Disease
    Creighton T. Tuzon, Diana Rigueur, Amy Elizabeth Merrill · 2019 · Current Osteoporosis Reports
  63. The Na,K-ATPase acts upstream of phosphoinositide PI(4,5)P2 facilitating unconventional secretion of Fibroblast Growth Factor 2
    Cyril Legrand, Roberto Saleppico, Jana Sticht, Fabio Lolicato, Hans‐Michael Müller, Sabine Wegehingel, Eleni Dimou, Julia P. Steringer, Helge Ewers, Ilpo Vattulainen et al. · 2020 · Communications Biology
  64. FGF4 improves hepatocytes ferroptosis in autoimmune hepatitis mice via activation of CISD3
    Huimian Jiang, Yan Fang, Yuxin Wang, Ting Li, Hongwei Lin, Jing Lin, Tongtong Pan, Qingxiu Liu, Jiaojian Lv, Dazhi Chen et al. · 2023 · International Immunopharmacology
  65. Region-specific regulation of cell proliferation by FGF receptor signaling during the Wolffian duct development
    Mika Okazawa, Aki Murashima, Masayo Harada, Naomi Nakagata, Masafumi Noguchi, Mitsuru Morimoto, Tadashi Kimura, David M. Ornitz, Gen Yamada · 2015 · Developmental Biology
  66. Extracellular Signal-Regulated Kinase Signaling Regulates the Opposing Roles of JUN Family Transcription Factors at ETS/AP-1 Sites and in Cell Migration
    Nagarathinam Selvaraj, Justin A. Budka, Mary W. Ferris, Joshua P. Plotnik, Peter C. Hollenhorst · 2014 · Molecular and Cellular Biology
  67. FGF1‐mediated cardiomyocyte cell cycle reentry depends on the interaction of FGFR‐1 and Fn14
    Tatyana Novoyatleva, Amna Sajjad, Denys Pogoryelov, Chinmoy Patra, RALPH THEO SCHERMULY, Felix Benedikt Engel · 2014 · The FASEB Journal
  68. The FgfrL1 receptor is required for development of slow muscle fibers
    Ruth Amann, Stefan Wyder, Anne Michele Slavotinek, Beat Trüeb · 2014 · Developmental Biology
  69. Interactions That Influence the Binding of Synthetic Heparan Sulfate Based Disaccharides to Fibroblast Growth Factor-2
    Yi-Ching Li, I-Hsin Ho, Chiao‐Chu Ku, Yong‐Qing Zhong, Yu‐Peng Hu, Zhi‐Geng Chen, Chun‐Yen Chen, Wei‐Chen Lin, Medel Manuel L. Zulueta, Shang‐Cheng Hung et al. · 2014 · ACS Chemical Biology
  70. Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors
    Riccardo Castelli, Arianna Giacomini, Mattia Anselmi, Nicole Bozza, Federica Vacondio, Silvia Rivara, Sara Matarazzo, Marco Presta, Marco Mor, Roberto Ronca · 2016 · Journal of Medicinal Chemistry
  71. FGFR-targeted therapeutics for the treatment of breast cancer
    Antonella De Luca, Daniela Frezzetti, Marianna Gallo, Nicola Normanno · 2017 · Expert Opinion on Investigational Drugs
  72. The causal associations between growth factors and constipation: a two-sample Mendelian randomization study
    Jiachen Wang, Mingyi Yang, Ke Xu, Xianjie Wan, Jiale Xie, Hui Yu, Jiaxin Fang, Zehua Wang, Peng Xu · 2023 · Frontiers in Physiology
  73. Thermo-reversible injectable gel based on enzymatically-chopped low molecular weight methylcellulose for exenatide and FGF 21 delivery to treat types 1 and 2 diabetes
    Jang Kyoung Kim, Changhun Yoo, Yong Hoon Cha, Yong‐Hee Kim · 2014 · Journal of Controlled Release
  74. Bile acids synthesis decreases after laparoscopic sleeve gastrectomy
    Alex Escalona, Rodrigo Muñoz, Verónica Irribarra P, Sandra Solari, Fidel A. Allende, Juan Francisco Miquel · 2015 · Surgery for Obesity and Related Diseases
  75. Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing
    Yan Weng, Tetsuya Ishino, Annette Sievers, Saswata Talukdar, J Chabot, Amy Sze Pui Tam, Weili Duan, Kelvin M. Kerns, Eric A. Sousa, Tao He et al. · 2018 · Scientific Reports
  76. Beige Fat, Adaptive Thermogenesis, and Its Regulation by Exercise and Thyroid Hormone
    Kevin J. Phillips · 2019 · Biology
  77. Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling
    Shilpi Agrawal, Sanhita Maity, Zeina Alraawi, Musaab Al-Ameer, Thallapuranam Krishnaswamy Suresh Kumar · 2020 · Current Drug Targets
  78. Identification of a novel aFGF-binding peptide with anti-tumor effect on breast cancer from phage display library
    Xiaoyong Dai, Cui-Zan Cai, Fei Xiao, Yaoling Xiong, Yadong Huang, Qihao Zhang, Qi Xiang, Guofeng Lou, Mengyang Lian, Zhijian Su et al. · 2014 · Biochemical and Biophysical Research Communications
  79. Integration of Multiple Signaling Pathways Determines Differences in the Osteogenic Potential and Tissue Regeneration of Neural Crest-Derived and Mesoderm-Derived Calvarial Bones
    Kshemendra Senarath-Yapa, Shuli Li, Nathaniel P. Meyer, Michael Thornton Longaker, Natalina Quarto · 2013 · International Journal of Molecular Sciences
  80. Combinatorial effects of epidermal growth factor, fibroblast growth factor 2 and insulin-like growth factor 1 on trophoblast cell proliferation and embryogenesis in cattle
    Markus Ming Xie, Sarah R. McCoski, Sally Johnson, M.L. Rhoads, Alan D. Ealy · 2015 · Reproduction Fertility and Development
  81. Targeting Fibroblast Growth Factor Receptor 1 for Treatment of Soft-Tissue Sarcoma
    Priya Chudasama, Marcus Renner, Melanie Straub, Sadaf Shabbir Mughal, Barbara Hutter, Zeynep Koşaloğlu‐Yalçın, Ron Schweßinger, Matthias Scheffler, Ingo Alldinger, Simon J. Schimmack et al. · 2016 · Clinical Cancer Research
  82. Preparation and in vitro evaluation of FGF-2 incorporated carboxymethyl chitosan nanoparticles
    Cong-Thuan Nguyen, Thanh-Thao Nguyen, Thu-Thuy Nguyen, Phuong Phong Thi Nguyen, Anh Dzung Nguyen, Linh T. Tran, Hieu Tran‐Van · 2017 · Carbohydrate Polymers
  83. Sulfated glycans engage the Ang–Tie pathway to regulate vascular development
    Matthew E. Griffin, Alexander W. Sorum, Gregory M. Miller, William A. Goddard, Linda C. Hsieh‐Wilson · 2020 · Nature Chemical Biology
  84. Liver organoid culture methods
    Yiqing Hu, Xiaoyi Hu, Jia Cheng Luo, Jiacheng Huang, Yaohan Sun, Haoyu Li, Yinbiao Qiao, Hao Wu, Jianhui Li, Lin Zhou et al. · 2023 · Cell & Bioscience
  85. Molecular Profile of Intrahepatic Cholangiocarcinoma
    Wellington Andraus, Francisco Tustumi, José Donizeti de Meira Júnior, Rafael Soares Nunes Pinheiro, Daniel Reis Waisberg, Liliana Ducatti, Rubens Macedo Arantes, Vinicius Rocha‐Santos, Rodrigo Bronze de Martino, Luiz Augusto Carneiro D′Albuquerque · 2023 · International Journal of Molecular Sciences
  86. Small-Molecule Protein Tyrosine Kinase Inhibitors for the Treatment of Metastatic Prostate Cancer
    Gary E. Gallick, Paul Gettys Corn, Amado J. Zurita, Sue-Hwa Lin · 2011 · Future Medicinal Chemistry
  87. Fibroblast growth factor (Fgf) signaling pathway regulates liver homeostasis in zebrafish
    Su-Mei Tsai, Dawei Liu, Wen-Pin Wang · 2012 · Transgenic Research
  88. Full-scale, three-dimensional simulation of early-stage tumor growth: The onset of malignancy
    Jiangping Xu, Guillermo Vilanova, Héctor Gómez · 2016 · Computer Methods in Applied Mechanics and Engineering
  89. FGF 11 induced by hypoxia interacts with HIF ‐1α and enhances its stability
    Kyeong Won Lee, Hyung‐Soon Yim, Jihye Shin, Cheolju Lee, Jung‐Hyun Lee, Jae‐Yeon Jeong · 2016 · FEBS Letters
  90. Effects of central FGF21 infusion on the hypothalamus–pituitary–thyroid axis and energy metabolism in rats
    Ümit Yılmaz, Suat Tekin, Mehmet Tevfik Demir, Yılmaz Çiğremiş, Süleyman Sandal · 2018 · The Journal of Physiological Sciences
  91. The Roles of Endo-Lysosomes in Unconventional Protein Secretion
    Juhyung Lee, Yihong Ye · 2018 · Cells
  92. Basic fibroblast growth factor accelerates myelin debris clearance through activating autophagy to facilitate early peripheral nerve regeneration
    Yongsheng Jiang, Jiahong Liang, Rui Li, Yan Peng, JiangLi Huang, Lijiang Huang · 2021 · Journal of Cellular and Molecular Medicine
  93. Phage-Displayed Peptides for Targeting Tyrosine Kinase Membrane Receptors in Cancer Therapy
    Annamaria Aloisio, Nancy Nisticò, Selena Mimmi, Domenico Maisano, Eleonora Vecchio, Giuseppe Fiume, Enrico Iaccino, Ileana Quinto · 2021 · Viruses
  94. Structural insights into the potency and selectivity of covalent pan-FGFR inhibitors
    Lingzhi Qu, Xiaojuan Chen, Hudie Wei, Ming Guo, Shuyan Dai, Longying Jiang, Jun Li, Sitong Yue, Zhuchu Chen, Yongheng Chen · 2022 · Communications Chemistry
  95. Innovative Medicine
    Kazuwa Nakao, Nagahiro Minato, Shinji Üemoto · 2015 · Springer eBooks
  96. Polydopamine modified acellular dermal matrix sponge scaffold loaded with a-FGF: Promoting wound healing of autologous skin grafts
    Lianglong Chen, Jun Ma, Yujia Chen, Chaoyang Huang, Zijun Zheng, Yanbin Gao, Ziwei Jiang, Xuerong Wei, Yujie Peng, Shengxiang Yu et al. · 2022 · Biomaterials Advances
  97. Design and Synthesis of Fibroblast Growth Factor Receptor (FGFR) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Cancer.
    Guo-Quan Wan, Zhanzhan Feng, Qiang-Sheng Zhang, Xiao Li, Kai Ran, H. Feng, Tianwen Luo, Shuyan Zhou, Chang Su, Wei Wei et al. · 2022 · Journal of Medicinal Chemistry
  98. Fibroblast Growth Factors for Nonalcoholic Fatty Liver Disease: Opportunities and Challenges
    Haoyu Tian, Shuairan Zhang, Ying Liu, Yifan Wu, Dianbao Zhang · 2023 · International Journal of Molecular Sciences
  99. Neuroprotection of neurotrophin-3 against focal cerebral ischemia/reperfusion injury is regulated by hypoxia-responsive element in rats
    J. Zhang, Q. Shi, Pingyuan Yang, X. Xu, X. Chen, Qi Chen, Jianzhi Zhang, Haixia Lü, Bing–Qiao Zhao, Ping Zheng et al. · 2012 · Neuroscience
  100. Imaging and quantifying solute transport across periosteum: Implications for muscle–bone crosstalk
    Xiaohan Lai, Christopher Price, X. Lucas Lu, Liyun Wang · 2014 · Bone